meldepliktige handler fra primærinnsidere

← Alle transaksjoner

Thor Medical ASA: Allocation of shares to primary insiders and their close associates in the Private Placement

Thor Medical ASA (TRMED) · publisert 2024-12-11 23:55 · vis på NewsWeb

Transaksjoner

PersonRolleTypeVolumPrisDatoISINHandelsplassTolket via
Jasper Kurth Person discharging managerial responsibilities CEOother400 0002,5 NOK2024-12-11NO0010597883Outside trading venue NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19rules
B GOOD INDUSTRIES AS, reg.no. 931 184 113 nærståendeA close associate of person discharging managerial responsibilities A close associate of CFO Brede Ellingsæter,other400 0002,5 NOK2024-12-11NO0010597883Outside trading venue NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19rules
Sindre Hassfjell Person discharging managerial responsibilities CTOother80 0002,5 NOK2024-12-11NO0010597883Outside trading venue NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19 NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19rules
Ludvik Sandnes Person discharging managerial responsibilities Chair of the board of directorsother140 0002,5 NOK2024-12-11NO0010597883Outside trading venuerules
Alf Bjørseth Person discharging managerial responsibilities Senior advisorother400 0002,5 NOK2024-12-11NO0010597883Outside trading venue NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19rules
Scatec Innovation AS nærståendeA close associate of person discharging managerial responsibilities A close associate of John Andersen, member of the boardother12 000 0002,5 NOK2024-12-11NO0010597883Outside trading venuerules

Vedlegg

Meldingstekst

12.12.2024 00:55:06 CET | Thor Medical ASA | Mandatory notification of trade primary insiders Oslo, Norway, 12 December 2024: Reference is made to the stock exchange announcement by Thor Medical ASA (the "Company") on 11 December 2024 regarding a private placement of new shares to be issued by the Company (the "Private Placement"). The following primary insiders and close associates have been allocated shares in the Private Placement, as further specified in the attached notification forms: * Scatec Innovation AS, a close associate of board member John Andersen, has been allocated 12,000,000 shares ; * Jasper Kurth, the CEO, has been allocated 400,000 shares; * Sindre Hassfjell the CTO, has been allocated 80,000 shares; * Alf Bjørseth, SVP Business Development, has been allocated 400,000 shares; * Ludvik Sandnes, the chair of the board, has been allocated 140,000 shares; and * B Good Industries AS, a close associated of primary insider Brede Ellingsæter the CFO, has been allocated 400,000 shares; This information is subject to disclosure requirements pursuant to the EU Market Abuse Regulation article 19 (3) and the Norwegian Securities Trading Act section 5-12. Contacts Brede Ellingsæter, CFO, Thor Medical ASA, +47 472 38 440, brede.ellingseter@thormedical.com ABOUT THOR MEDICAL ASA Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'. To learn more, visit www.thormedical.no - http://www.thormedical.no - https://www.thormedical.no. ATTACHMENTS Download announcement as PDF.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18356877/5408/Download%20announce ment%20as%20PDF.pdf 20241211 - Primary insider notifications.pdf - https://kommunikasjon.ntb.no/ir-files/17848634/18356877/5407/20241211%20-%20Prim ary%20insider%20notifications.pdf